VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis
Cancer and neurodegeneration are different classes of diseases that share the involvement of mitochondria in their pathogenesis. Whereas the high glycolytic rate (the so-called Warburg metabolism) and the suppression of apoptosis are key elements for the establishment and maintenance of cancer cells...
Main Authors: | Andrea Magrì, Simona Reina, Vito De Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fchem.2018.00108/full |
Similar Items
-
VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress
by: Varda Shoshan-Barmatz, et al.
Published: (2017-09-01) -
VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases
by: Varda Shoshan-Barmatz, et al.
Published: (2020-10-01) -
Selective induction of cancer cell death by VDAC1‐based peptides and their potential use in cancer therapy
by: Anna Shteinfer‐Kuzmine, et al.
Published: (2018-06-01) -
Recombinant yeast VDAC2: a comparison of electrophysiological features with the native form
by: Andrea Magrì, et al.
Published: (2019-07-01) -
Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC
by: Pierpaolo Risiglione, et al.
Published: (2021-05-01)